CLINICAL TRIALS AND EVALUATIONS
One of the key elements in the production of recombinant proteins, as active ingredient drugs, is safety and clinical evaluation. In Pooyesh Darou Pharmaceuticals we spend large amounts of our annual budget for carrying multi‐center clinical studies.
Many university hospitals, private centers and well‐known scientists are collaborating with Pooyesh Darou Pharmaceuticals:
- Tehran University of Medical Sciences (TUMS)
- Digestive Research Center (DDRC), Shariati Hospital, TUMS
- Gastroenterology and Hepatology Center, Imam Khomeini Hospital, TUMS
- Oncology and Blood Disease Research Center, Imam Khomeini Hospital, TUMS
- Shahid Beheshti University of Medical Sciences (SBUMS)
- Nephrology Research Center, Shahid Modarres Hospital, SBUMS
- Kidney Disease Research Center, Shahid Labbafi‐Nezhad Hospital, SBUMS
- Helal Ahmar Hospital (Red Cross hospital)
- Shiraz University of Medical Sciences (SUMS)
- Bone Marrow Transplant Research Center
- Kermanshah University of Medical Sciences (KUMS)
- Digestive and Liver Disease Research Center, KUMS
- Mashhad University of Medical Sciences (MUMS)
- Nephrology Research Center, Imam Reza Hospital, MUMS
- Iranian Society of Nephrology
- Iranian Society of Hepatology and Gastroenterology
PRODUCTS
Recombinant Pharmaceutical Products:
- PDferon‐B® (interferon alpha‐2b) 3MIU injection IV, Sc
- PDferon‐B® (interferon alpha‐2b) 5MIU injection IV, Sc
- PDgrastim® (rG‐CSF, Filgrastim) 300μg injection IV, Sc
- PDpoetin® (rh‐Erythropoietin alpha) 2000IU injection IV, Sc
- PDpoetin® (rh‐Erythropoietin alpha) 4000IU injection IV, Sc
- PDpoetin® (rh‐Erythropoietin alpha) 10000IU injection IV, Sc
- Pegaferon® (pegylated interferon alpha‐2a) 180μg injection IV, Sc
Products under development:
- Interferon beta‐1a
- Interferon beta‐1b
- Interleukins
- FSH
- MABs
- Triptorelin acetate, 3.75mg
